--- title: "KBRA Releases Research – CMBS Loan Performance Trends: September 2026" type: "News" locale: "en" url: "https://longbridge.com/en/news/300592091.md" description: "KBRA's September 2026 CMBS report shows the 30+ day delinquency rate rose 9 bps to 7.7%, driven by office and multifamily sectors, while the overall distress rate fell 4 bps to 10.3%. Office distress decreased due to loan resolutions, whereas multifamily distress increased significantly. Conduit distress rose year-over-year, contrasting with a decline in single-borrower/large-loan distress." datetime: "2026-09-30T14:42:28.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/300592091.md) - [en](https://longbridge.com/en/news/300592091.md) - [zh-HK](https://longbridge.com/zh-HK/news/300592091.md) generator: "portal-rs" --- # KBRA Releases Research – CMBS Loan Performance Trends: September 2026 In New York, KBRA has published a report on U.S. commercial mortgage-backed securities (CMBS) loan performance for September 2026. Among KBRA-rated U.S. private label CMBS, the 30+ day delinquency rate rose by 9 basis points to reach 7.7% in September, up from 7.6% in August. However, the distress rate, which includes delinquent and current-but-specially-serviced loans, decreased by 4 basis points during this period. These findings highlight the evolving trends in CMBS loan performance for September 2026. ## Related News & Research - [Nu Holdings Publishes Third-Quarter 2026 Earnings Call Transcript](https://longbridge.com/en/news/305484611.md) - [Healthcare Of Ontario Pension Plan Trust Fund Cuts Share Stake In Nvidia, Meta, Cisco](https://longbridge.com/en/news/305510976.md) - [AST SpaceMobile (ASTS) Gains Partner Appeal As Direct To Device Rivalry Grows](https://longbridge.com/en/news/305487052.md) - [Anthropic’s Valuation Target Has Slipped From $2 Trillion to Under $1.5 Trillion. Here’s Why](https://longbridge.com/en/news/305493732.md) - [Zai Lab reports sustained biomarker inhibition with ZL-1503 in Phase 1 trial](https://longbridge.com/en/news/305458594.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**